Decreased Circulating Levels of Tumor Necrosis Factor-alpha in Postmenopausal Women during Consumption of Soy-Containing Isoflavones
Remember that the latest and greatest class of medications to hit the market are the “biological agents,” such as the TNF-alpha blockers like Remicade and Enbral. But I have serous long term concerns with this approach, as TNF-alpha is one of our body’s ways of dealing with cancer cells. Well, instead of blocking the action of TNF-alpha, how about the novel concept of less of it in the first place? We already know that lowering insulin levels can lower TNF-alpha levels, but now we see a whopping 66.7% reduction in circulating TNF-alpha levels after 10 weeks with use of a soy drink. Lets compare.
TNF-alpha blockers: probably increase risk of cancer, infections, TB, blah, blah, blah. About $1K/month. Soy: protects against high cholesterol, lowers risk of breast and endometrial cancer, protects bone, some people allergic. About $35/month. Look on your rheumatologists face: priceless.